Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 95, Issue -, Pages 780-788Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2017.08.074
Keywords
Thymoquinone-rich fraction; Thymoquinone; Nigella sativa; Nanoemulsion; Amyloid-beta; High fat/cholesterol diet
Funding
- Ministry of Higher Education, Malaysia through the Fundamental Research Grant Scheme [FRGS/1/2013/SG05/UPM/01/3]
Ask authors/readers for more resources
Though the causes of Alzheimer's disease (AD) are yet to be understood, much evidence has suggested that excessive amyloid-beta (A beta) accumulation due to abnormal amyloid-beta precursor protein (APP) processing and A beta metabolism are crucial processes towards AD pathogenesis. Hence, approaches aiming at APP processing and A beta metabolism are currently being actively pursued for the management of AD. Studies suggest that high cholesterol and a high fat diet have harmful effects on cognitive function and may instigate the commencement of AD pathogenesis. Despite the neuropharmacological attributes of black cumin seed (Nigella sativa) extracts and its main active compound, thymoquinone (TQ), limited records are available in relation to AD research. Nanoemulsion (NE) is exploited as drug delivery systems due to their capacity of solubilising non-polar active compounds and is widely examined for brain targeting. Herewith, the effects of thymoquinone-rich fraction nanoemulsion (TQRFNE), thymoquinone nanoemulsion (TQNE) and their counterparts' conventional emulsion in response to high fat/cholesterol diet (HFCD)-induced rats were investigated. Particularly, the A beta generation; APP processing, beta-secretase 1 (BACE1), gamma-secretases of presenilin 1 (PSEN1) and presenilin 2 (PSEN2), A beta degradation; insulin degrading enzyme (IDE), A beta transportation; low density lipoprotein receptor-related protein 1 (LRP1) and receptor for advanced glycation end products (RAGE) were measured in brain tissues. TQRFNE reduced the brain A beta fragment length 1-40 and 1-42 (A beta 40 and A beta 42) levels, which would attenuate the AD pathogenesis. This reduction could be due to the modulation of beta- and gamma-secretase enzyme activity, and the A beta degradation and transportation in/out of the brain. The findings show the mechanistic actions of TQRFNE in response to high fat and high cholesterol diet associated to A beta generation, degradation and transportation in the rat's brain tissue.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available